RxDoctor Payments Data

Barbara Carrascosa-Andre

Adult Health · Santa Ana, CANPI 1447589619

Payments from drug & device makers

$2,186in general payments, 2019–2025

Across 85 payments — averaging $25.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Exelixis Inc.$216
  • Incyte Corporation$179
  • Astellas Pharma US Inc$177
  • Sumitomo Pharma America, Inc.$159
  • Tolmar, Inc.$154
  • Medtronic$125
  • plus $1K from 24 others

What the payments were for

  • Food & beverage$1,90187%
  • Education$28513%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,186 in reported general payments places this provider in the 80th percentile of 785 adult health providers in California.

See all adult health providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
GemtesaVibegron30$27,418
MyrbetriqMirabegron17$16,450
Silodosin25$2,044
Tamsulosin Hcl124$1,961
Estradiol20$1,313
NitrofurantoinNitrofurantoin Macrocrystal27$878
Testosterone11$854
Alfuzosin Hcl ErAlfuzosin Hcl26$791
Potassium Citrate ErPotassium Citrate11$729
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav59$643
Finasteride42$463
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst43$427
Doxycycline Hyclate13$189
Cephalexin29$172
Trospium Chloride12$130

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Sumitomo Pharma America, Inc.Gemtesa$159$27,41830 claims
Astellas Pharma US IncMyrbetriq$177$16,45017 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 785 adult health providers in California.

Other adult health in Santa Ana

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →